See also this year's filing and all EDGAR filings for this company.
PDF Report 0000707511_2020_REGENERX_BIOPHARMACEUTICALS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.04756679651067098, 'aggregate_val': 711760, 'exp_sum': 747307, 'exp_to_value': {'AssetsCurrent': 681555, 'IntangibleAssetsNetIncludingGoodwill': 0, 'PropertyPlantAndEquipmentNet': 0, 'remainder_Assets': 65752}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000707511')"} |
Graph
Absolute values for 0000707511, REGENERX BIOPHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 681,555 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 30,205 |
| 4 | LiabilitiesCurrent | 242,473 |
| 5 | LiabilitiesNoncurrent | 2,101,325 |
| 6 | remainder_Liabilities | 708,070 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,273,536 |
| 9 | ResearchAndDevelopmentExpense | 65,107 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 76,762 |
| 12 | remainder_NetIncome | -142,366 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 711,760 |
| 1 | Liabilities | 3,051,868 |
| 2 | Expenses | 1,338,643 |
| 3 | Revenues | 76,762 |
| 4 | StockholdersEquity | -2,340,108 |
| 5 | NetIncome | -1,404,247 |
| 6 | ComprehensiveNetIncome | -1,404,247 |
| 7 | BaseVar | 2,660,700 |
| 8 | EconomicCapitalRatio | -2.89 |
Edgar->Model Mapping
Feature Distribution
Change over Time
